Tr1X is pioneering a revolutionary category of regulatory T cell-based products aimed at curing autoimmune and inflammatory diseases, with the potential to significantly improve the lives of patients.
www.tr1x.bio/
Bill Lis
Chief Executive Officer
Maria Grazia Roncarolo, MD
Co-founder, President and Head of R&D
David de Vries, MPhil
Co-founder, Chief Operating Officer